PRME — Prime Medicine Share News
0.000.00%
Last trade - 00:00- $676.54m
- $581.46m
- $4.63m
Brief: Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results And Provides Business Update
Brief: Prime Medicine Announces Recent Progress and Highlights 2023 Strategic Priorities
Brief: Prime Medicine Announces Closing Of Upsized Initial Public Offering
Brief: Prime Medicine Shares Open At Premium of 11.6% in Nasdaq Debut VS IPO Price
Biotech firm Prime Medicine valued at $1.8 bln in strong debut (updated)
Biotech firm Prime Medicine valued at $1.8 bln in strong debut
Gene editing co Prime Medicine rises after IPO upsize
Brief: Prime Medicine Prices Upsized Initial Public Offering Of 10.3 Mln Common Shares At $17.00/Share